Elvium Life Sciences Announces Publication of New Data Analysis from Studies with FOQUEST® Controlled Release Capsules Examining Sleep Quality Outcomes in Adults with ADHD

By |2021-08-26T22:52:32-04:00August 26th, 2021|

Elvium Life Sciences Announces Publication of New Data Analysis from Studies with FOQUEST® Controlled Release Capsules Examining Sleep Quality Outcomes in Adults with ADHD Toronto, Ontario, August 25, 2021 – Elvium Life Sciences, an independent associated company of Purdue Pharma (Canada), announced the publication of post-hoc analyses of data from a randomized, double‑blind, 4-week, [...]